Search Awardees

Pharmapro Consulting LogoPharmapro Consulting

UEI: JNPZJQXE6MR7 • CAGE: 89PU7

Overview

Awardee Type
Parent
Federal Capability Statement
We support IND, NDA, BLA, ANDA, Fast Track, Breakthrough Therapy, and Priority Review & Biosimilars Our expertise: Clinical Pharmacology, Preclinical, ADME, DMPK PK Data analysis and Reporting PK/PD Modeling and Simulation Pop PK Analysis Regulatory Strategy Medical & Manuscript writing Data management and CDISC Mapping
Keywords
PharmaPro Consulting, established in 2015. We support IND, NDA, BLA, ANDA, Fast Track, Breakthrough Therapy, Priority Review, Biosimilars, Our expertise: Clinical Pharmacology, Preclinical, ADME, DMPK PK Data analysis and Reporting, PK/PD Modeling and Simulation, Pop PK Analysis, Regulatory Strategy, Medical & Manuscript writing, Data management and CDISC Mapping
Headquarters
Hillsborough, NJ
United States
Federal recipient PHARMAPRO CONSULTING INC (UEI JNPZJQXE6MR7, CAGE 89PU7) is headquartered in Hillsborough NJ. Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology). The partnership was founded in February 2015 and federally registered in March 2019.

Federal Registration and Certifications

Legal Name
PHARMAPRO CONSULTING INC
UEI
JNPZJQXE6MR7
CAGE Code
89PU7
SBA Certifications
None
Self Certifications
Economically Disadvantaged Women Small Owned Business
Minority Owned Business
Self-Certified Small Disadvantaged Business
Subcontinent Asian (Asian-Indian) American Owned
Woman Owned Business
Woman Owned Small Business
Entity Structure
Partnership or Limited Liability Partnership

People

Vendor contacts at Pharmapro Consulting

Subscribe to find 500K+ key government decision markers

Free Trial Schedule Demo